Fault Lines: Trump’s Tariffs and the Fracturing of US-China Trade
The Trump administration's unprecedented tariffs are accelerating US-China decoupling, compelling business leaders to rethink strategies after decades of established trade norms.
Marley Brocker
15 min read
Retaliation Ripple: Sector-Level Fallout from U.S. Trade Policy
As the second Trump presidency pushes tariffs to their highest levels in a century, some industries are especially impacted by coinciding retaliatory tariffs.
Dmitry Diment
14 min read
Cliffs and Shortages: A Global Analysis of Pharmaceutical Manufacturing
Challenging headwinds will require global pharmaceutical manufacturers to take more innovative approaches to cushion their fall.
Marley Brocker
12 min read
Industry Implications of Oregon’s Approval of Proposition 109
In this article, IBISWorld provides an insight into the implications of Oregon’s approval of Proposition 109.
IBISWorld
2 min read-
Operation Warp Speed: COVID-19 Vaccine Development (Part 2)
IBISWorld’s pharmaceuticals analyst Dan Spitzer tracks the progress of the COVID-19 vaccine as it enters phase three trials and some challenges the final product could face.
IBISWorld
3 min read -
Operation Warp Speed: COVID-19 Vaccine Development (Part 1)
IBISWorld provides an update on the race to develop a COVID-19 vaccine.
IBISWorld
3 min read -
Industry Impacts of the US/Canada Border Closure
The industry effects of the US/Canada border closure are largely minimal, yet result in negative externalities for transportation and pharmaceutical industries.
Eva Koronios
3 min read
- «
- ‹
- 1
- ›
- »